2017
DOI: 10.1139/cjc-2017-0108
|View full text |Cite
|
Sign up to set email alerts
|

Improved large-scale synthesis and characterization of small and medium generation PAMAM dendrimers

Abstract: Dendrimers are promising polymers for biomedical applications; however, most dendrimer formulations have failed to move from laboratory science to upscaled products for preclinical testing or GMP production. This publications reports on an improved large-scale PAMAM dendrimer synthesis that is suitable to manufacture large amounts of highly pure and monodisperse dendrimers of generations G0–G5. Furthermore, an extended analytical guideline how to characterize PAMAM dendrimers with NMR, HPLC, SEC-MALS, ESI, MAL… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
28
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 28 publications
(30 citation statements)
references
References 35 publications
2
28
0
Order By: Relevance
“…The main challenge relies on preserving their purity and monodispersity upon up-scaled manufacture. Technical details with respect to improved reaction conditions and purification of half-and full-generation PAMAM dendrimers to overcome the critical limitations for upscaling this class of polymers are available elsewhere (Ficker et al, 2017).…”
Section: Dendrimersmentioning
confidence: 99%
“…The main challenge relies on preserving their purity and monodispersity upon up-scaled manufacture. Technical details with respect to improved reaction conditions and purification of half-and full-generation PAMAM dendrimers to overcome the critical limitations for upscaling this class of polymers are available elsewhere (Ficker et al, 2017).…”
Section: Dendrimersmentioning
confidence: 99%
“…To date, none of these systems has been used for multicargo delivery in the clinical setting, clearly illustrating the need for further research on their bioactivity and safety. [82c] Considering that these systems have become relatively easy to scale‐up, with emerging production techniques, such as ethanol injection, use of vertical stirred tank reactors, and micellar electrospray, showing narrow size distribution, good reproducibility, and appropriate stability, in the years to come, advancements in chemistry and functionalization are expected to address cytotoxicity and adequate cargo‐loading/protection issues, bridging in that way the gap between proof of concept and clinical translation.…”
Section: Self‐assembly Technologiesmentioning
confidence: 99%
“…It has furthermore a natural handle for attachment of a linker (the piperazine moiety) that should have minimal effect on the antimicrobial properties. A G0 DAB-core PAMAMdendrimer [38] ( Figure 2) was chosen as a compromise between multivalency, solubility of the conjugate and a wish to keep the molecular weight as low as possible. The molecular design is shown in Figure 3 and involves the covalent attachment of Ciprofloxacin via a linker to a small PAMAM-dendrimer.…”
Section: Resultsmentioning
confidence: 99%